Stock Markets Analysis & Opinion

Tesla (NASDAQ:TSLA) is working on a new music streaming service, called “TTunes,” based on new images from inside the tech company’s software.A Tesla insider, named...

(0:30) - Trump's Latest Rally In Arizona (3:00) - Snapchat's Positive Week(8:35) - Amazon's Buyout Of Whole Foods Finalized (19:00) - Uber Rumors: Jeff Immelt Top CEO Candidate (31:00) - Episode...

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:Broadridge Financial Solutions, Inc. (BR): This provider of investor communications and technology-driven solutions has witnessed...

International stocks have been the real winners this year courtesy of cheap valuations and improving economic growth in many parts of the world. After outperforming in the first half, these stocks...

Biogen Inc. (NASDAQ:BIIB) announced that its biosimilar version of AbbVie, Inc.’s (NYSE:ABBV) top-selling blockbuster drug, Humira has been approved by the European Commission. The...

Mylan N.V. (NASDAQ:MYL) and Japan-based Otsuka Pharmaceutical signed a license agreementto commercialize Deltyba (delamanid) in low- and middle-income countries, including South Africa and India....

Hurricane Harvey is expected to be classified a Category 3 hurricane before it strikes the coast of Southeast Texas this morning, jeopardizing the oil refinery industry located in and around Houston,...

Pure Storage Inc. (NYSE:PSTG) reported non-GAAP loss of 11 cents per share in the second quarter of fiscal 2018, which was narrower than the Zacks Consensus Estimate by 3 cents. The figure was also...

For Immediate ReleaseChicago, IL – August 25, 2017 – Zacks Equity Research Tyson Foods (NYSE: (NYSE:TSN) – Free Report)as the Bull of the Day, L Brands (NYSE: (NYSE:LB) –...

As summer vacation is coming to a close, it’s time for students to head back to colleges and schools. This time around, however, back-to-college and back-to-school spending is expected to reach...

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) announced that its regulatory applications for tezacaftor/ivacaftor (Kalydeco) combination have been accepted by the FDA and the European Medicines...

Fidelity is trimming total expenses to outdo Vanguard, the U.S. asset manager who has introduced the low-cost investment mantra. Fidelity has not only matched but also undercut the price Vanguard...

Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) announced FDA approval of its Gocovri for treating dyskinesia in patients with Parkinson's disease who are on levodopa-based therapy. This the first drug...

Companies with favorable efficiency levels are poised to be on investors’ radar irrespective of market conditions as price performance is believed to be positively correlated with the efficiency...